328 related articles for article (PubMed ID: 11533345)
1. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
Vermont Oxford Network Steroid Study Group
Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345
[TBL] [Abstract][Full Text] [Related]
2. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
3. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2012 May; (5):CD002058. PubMed ID: 22592683
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
[TBL] [Abstract][Full Text] [Related]
5. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams.
Kaempf JW; Campbell B; Sklar RS; Arduza C; Gallegos R; Zabari M; Brown A; McDonald JV
Pediatrics; 2003 Apr; 111(4 Pt 2):e534-41. PubMed ID: 12671173
[TBL] [Abstract][Full Text] [Related]
6. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2009 Jan; (1):CD001146. PubMed ID: 19160190
[TBL] [Abstract][Full Text] [Related]
7. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
[TBL] [Abstract][Full Text] [Related]
8. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
[TBL] [Abstract][Full Text] [Related]
9. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2009 Jan; (1):CD001145. PubMed ID: 19160189
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
Halliday HL; Patterson CC; Halahakoon CW;
Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
[TBL] [Abstract][Full Text] [Related]
11. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah V; Ohlsson A; Halliday HL; Dunn MS
Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
[TBL] [Abstract][Full Text] [Related]
12. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
[TBL] [Abstract][Full Text] [Related]
13. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
14. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
Bloomfield FH; Knight DB; Harding JE
J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
[TBL] [Abstract][Full Text] [Related]
15. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2001; (1):CD001146. PubMed ID: 11279706
[TBL] [Abstract][Full Text] [Related]
16. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2003; (1):CD001144. PubMed ID: 12535400
[TBL] [Abstract][Full Text] [Related]
17. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
[TBL] [Abstract][Full Text] [Related]
18. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA
Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252
[TBL] [Abstract][Full Text] [Related]
19. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants.
Romagnoli C; Zecca E; Vento G; De Carolis MP; Papacci P; Tortorolo G
Intensive Care Med; 1999 Jul; 25(7):717-21. PubMed ID: 10470576
[TBL] [Abstract][Full Text] [Related]
20. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
Yeh TF; Lin YJ; Hsieh WS; Lin HC; Lin CH; Chen JY; Kao HA; Chien CH
Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
